Caffeine Completed Phase 2 / 3 Trials for Excessive Daytime Somnolence / Parkinson's Disease (PD) Treatment

IndicationsStatusPurposePhase
CompletedTreatment2 / 3
clinicaltrials.gov IdentifierTitleDrugs
NCT01190735Caffeine for Motor Manifestations of Parkinson's Disease